Guidelines on the selection and use of therapeutic products to treat haemophilia and other hereditary bleeding disorders
- 28 January 2003
- journal article
- guideline
- Published by Wiley in Haemophilia
- Vol. 9 (1) , 1-23
- https://doi.org/10.1046/j.1365-2516.2003.00711.x
Abstract
Evidence based guidelines are presented on the selection and use of therapeutic products to treat haemophilia. These guidelines offer advice based on the best published scientific and medical information. They will be reviewed regularly by UKHCDO Advisory Committee. Included are details of therapeutic products available in the UK to treat patients with haemophilia and other bleeding disorders and the background information on which the recommendations are based are presented.Keywords
This publication has 62 references indexed in Scilit:
- Measurement of factor VIII activity of B-domain deleted recombinant factor VIIISeminars in Hematology, 2001
- Are recombinant products really infection risk free?Haemophilia, 2001
- THE DIAGNOSIS and MANAGEMENT OF FACTOR VIII and IX INHIBITORS: A GUIDELINE FROM THE UK HAEMOPHILIA CENTRE DOCTORS' ORGANIZATION (UKHCDO)British Journal of Haematology, 2000
- The effect of monoclonal or ion‐exchange purified factor VIII concentrate on HIV disease progression: a prospective cohort comparisonBritish Journal of Haematology, 1998
- A new variant of Creutzfeldt-Jakob disease in the UKPublished by Elsevier ,1996
- The Need for Highly Purified Products to Treat Hemophilia BActa Haematologica, 1995
- Risks of immunodeficiency, AIDS, and death related to purity of factor VIII concentrateThe Lancet, 1994
- A cross‐over pharmacokinetic and thrombogenicity study of a prothrombin complex concentrate and a purified factor IX concentrateBritish Journal of Haematology, 1994
- Stability of factor VIII concentrates after reconstitutionAmerican Journal of Hematology, 1994
- Reduced coagulation activation following infusion of a highly purified factor IX concentrate compared to a prothrombin complex concentrateBritish Journal of Haematology, 1993